Quote:
Originally Posted by Materly
Ahh soo.
But do you not find it absolutely appealing that if schiz vulnerability can be tied down to expression of 1 gene , it means that people who test for this 'version' can be targeted efficiently through treatment. The multgenic modal will only line the pockets of the drug companies , regardless if it has merit. What do we get by saying 'sh*ts complicated' we must will it: complexity to simplicity , that's what the great great people in our history did
|
I think it's going to be like treating cancer where there is more than one type, that's all. It's not that this isn't exciting but I don't know that they've even found an equivalent version mutation in humans with sz as this is just the beginning in mice and a lot of stuff never make it past that stage. Plus it's an actin regulatory gene I think it's just weird that's all. I don't put a lot of faith in the article its kind of sensationalist.